ABBVIE INC. v. ALKEM LABORATORIES LTD. - 3:26-cv-09363

ABBVIE INC. v. ALKEM LABORATORIES LTD. (Case No. 3:26-cv-09363), filed on Jul 24, 2026 in the District Court, D. New Jersey involving patent infringement. This case involves patent infringement claims between the parties. Explore details about the litigants, key filings, and major docket updates.

Case Details

Case Number
3:26-cv-09363
Filing Date
Jul 24, 2026
Cause of Action
Patent Infringement
Status
-
Court
District Court, D. New Jersey
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

Parties Involved

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
IRONWOOD PHARMACEUTICALS, INC. -
ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED -
ALKEM LABORATORIES LTD. -
ABBVIE INC. -

Patents Involved

This case involves 7 patents, each of which is central to the dispute. These patents may be subject to claims of infringement, challenges to their validity, or other issues concerning their scope and enforcement.

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Jul 24, 2026Corporate Disclosure Statement by ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED identifying ABBVIE INC. as Corporate Parent.. (LINARES, JOSE) (Entered: 07/24/2026)PACER Document
Jul 24, 2026Corporate Disclosure Statement by ABBVIE INC.. (LINARES, JOSE) (Entered: 07/24/2026)PACER Document
Jul 24, 2026COMPLAINT against ALKEM LABORATORIES LTD. ( Filing and Admin fee $ 405 receipt number ANJDC-17709732), Related Case Selected, filed by ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED, ALLERGAN SALES, LLC, IRONWOOD PHARMACEUTICALS, INC., ABBVIE INC.. (Attachments: # 1 Exhibit A - U.S. Patent No. 7,304,036, # 2 Exhibit B - U.S. Patent No. 8,933,030, # 3 Exhibit C - U.S. Patent No. 9,708,371, # 4 Exhibit D - U.S. Patent No, 8,802,628, # 5 Exhibit E - U.S. Patent No. 8,748,573, # 6 Exhibit F - U.S. Patent No. 10,675,325, # 7 Exhibit G - U.S. Patent No. 10,702,576, # 8 Civil Cover Sheet)(LINARES, JOSE) (Entered: 07/24/2026)PACER Document
Jul 24, 2026NOTICE of Appearance by MARK M. MAKHAIL on behalf of ABBVIE INC., ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED, ALLERGAN SALES, LLC, IRONWOOD PHARMACEUTICALS, INC. (MAKHAIL, MARK) (Entered: 07/24/2026)PACER Document
Jul 24, 2026Corporate Disclosure Statement by IRONWOOD PHARMACEUTICALS, INC.. (LINARES, JOSE) (Entered: 07/24/2026)PACER Document
Jul 24, 2026Corporate Disclosure Statement by ALLERGAN SALES, LLC identifying ABBVIE INC. as Corporate Parent.. (LINARES, JOSE) (Entered: 07/24/2026)PACER Document